Clinical Trials with Mesenchymal Stem Cells2017-08-28T22:43:39+00:00

Clinical Trials with MSCs

At the time of this writing, there are nearly 800 clinical trials for adult stem cell therapies using mesenchymal stem cells (MSCs) which are currently underway throughout the world.*

Detailed information about all such clinical trials is available by typing in “mesenchymal stem cell” in the search box for “Other Terms” at, a website of the U.S. National Institutes of Health. Leave the “Condition / Disease” box and the “Country” box blank, in order to include all conditions, all diseases, and all countries in the results.

This table, at the link below, lists data from all ongoing MSC clinical trials currently being conducted throughout the world, as divided into two broad categories: autologous (the first column, in which the donor and recipient are the same person), and allogeneic (the second column, in which the donor and recipient are different people). As you’ll be able to see, the allogeneic clinical trials greatly outnumber the autologous ones — due to the immune-privileged nature of umbilical cord blood-derived MSCs, as described on our Stem Cell Basics page.

Click here to see table, with data compiled from nearly 800 clinical trials currently underway throughout the world, using adult stem cells (specifically, mesenchymal stem cells, MSCs).



View Clinical Trials (pdf)